Salvá P - Search Results

1

Comparison of rufloxacin and norfloxacin effects on faecal flora.

Marco F, Giménez MJ, Jiménez de Anta MT, Marcos MA, Salvá P, Aguilar L. Marco F, et al. Among authors: salva p. J Antimicrob Chemother. 1995 Jun;35(6):895-901. doi: 10.1093/jac/35.6.895. J Antimicrob Chemother. 1995. PMID: 7559202 Clinical Trial.

2

Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers.

Aguilar L, Balcabao IP, Salvá P, Martín M, Costa J, Prieto J, Dal-ré R. Aguilar L, et al. Among authors: salva p. Antimicrob Agents Chemother. 1996 Jan;40(1):17-21. doi: 10.1128/AAC.40.1.17. Antimicrob Agents Chemother. 1996. PMID: 8787872 Free PMC article. Clinical Trial.

3

Pharmacokinetics of alfuzosin after single oral administration to healthy volunteers, of three different doses.

Salva P, Bianchetti G, Morselli P, Garcia-Teresa G, Costa J. Salva P, et al. Biopharm Drug Dispos. 1992 Nov;13(8):583-90. doi: 10.1002/bdd.2510130804. Biopharm Drug Dispos. 1992. PMID: 1358243 Clinical Trial.

4

Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications.

Salvà P, Costa J. Salvà P, et al. Clin Pharmacokinet. 1995 Sep;29(3):142-53. doi: 10.2165/00003088-199529030-00002. Clin Pharmacokinet. 1995. PMID: 8521677 Review.

5

Absolute bioavailability, pharmacokinetics, and urinary excretion of the novel antimigraine agent almotriptan in healthy male volunteers.

Jansat JM, Costa J, Salvà P, Fernandez FJ, Martinez-Tobed A. Jansat JM, et al. Among authors: salva p. J Clin Pharmacol. 2002 Dec;42(12):1303-10. doi: 10.1177/0091270002042012006. J Clin Pharmacol. 2002. PMID: 12463724 Clinical Trial.

6

Pharmacological properties of hirudin and its derivatives. Potential clinical advantages over heparin.

Monreal M, Costa J, Salva P. Monreal M, et al. Among authors: salva p. Drugs Aging. 1996 Mar;8(3):171-82. doi: 10.2165/00002512-199608030-00003. Drugs Aging. 1996. PMID: 8720743 Review.

7

Tolerability and safety of 0.1% diclofenac plus 0.3% tobramycin fixed-dose ophthalmic solution: a randomized, comparative, controlled study in healthy volunteers.

Salvá P, Costa J, Andreu D, Notivol R, Martínez M. Salvá P, et al. Methods Find Exp Clin Pharmacol. 1999 Apr;21(3):203-8. doi: 10.1358/mf.1999.21.3.534830. Methods Find Exp Clin Pharmacol. 1999. PMID: 10389123 Free article. Clinical Trial.

8

Repeated dose pharmacokinetics of pancopride in human volunteers.

Salva P, Costa J, Pérez-Campos A, Martínez-Tobed A. Salva P, et al. Biopharm Drug Dispos. 1994 Nov;15(8):643-51. doi: 10.1002/bdd.2510150803. Biopharm Drug Dispos. 1994. PMID: 7888596 Clinical Trial.

9

[Evaluation of the therapeutic risk].

Zapata A, Costa J, Salvà P. Zapata A, et al. Among authors: salva p. Med Clin (Barc). 1996 Mar 16;106(10):383-6. Med Clin (Barc). 1996. PMID: 8637279 Spanish. No abstract available.

10

Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain.

Salleras L, Domínguez A, Mata E, Taberner JL, Moro I, Salvà P. Salleras L, et al. Among authors: salva p. Public Health Rep. 1995 May-Jun;110(3):338-42. Public Health Rep. 1995. PMID: 7610227 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters